USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APTAKON, INC.
Address:
8333 HICKMAN MILLS DR
KANSAS CITY, MO 64132-2515
Phone:
N/A
URL:
N/A
EIN:
126165574
DUNS:
809981108
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $397,350.00 3

Award List:

High-Throughput Low Cost Production of Chromatin-Immunoprecipitation-Grade Antib

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$97,500.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Identifying the regulatory regions of the genome is critical for understanding the regulatory networks underlying human development and disease. Chromatin immunoprecipitation (ChIP) coupled with microarray (ChIP-chip) or sequencing (ChIP- seq) is a widely used… More

DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS FOR CANCE

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$149,857.00
Agency:
HHS
Principal Investigator:
Keith Kropp – (816) 510-7674
Abstract:
Many of the antibodies produced for cancer research are poorly characterized, exhibit suboptimal affinity or selectivity, and are time-consuming and expensive to produce. Alternative affinity capture reagents are therefore needed as reproducible, highly characterized, rapid, and cost-effective… More

SBIR TOPIC 294 PHASE I - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,993.00
Agency:
HHS
Principal Investigator:
Richard Suderman – 816-510-7674
Abstract:
The function of many cancer related proteins is modulated by modifications such as phosphorylation and glycosylation. The development of antibodies that recognize site-specific phosphorylation has vastly improved our understanding of signal transductionand cancer cell physiology and regulation.… More